LNAILunai Bioworks Inc. Common Stock

2.155USD-2.93%Mkt Cap: 9.77M $P/E:

Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and …

Key Statistics

Company
Market Cap9.77M $
Enterprise Value8.23M $
Revenue (TTM)20.94K $
Gross Profit20.94K $
Net Income (TTM)-178.01M $
Revenue/Share0.0080 USD
Last Price2.155 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees29
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA-0.84
EV/Revenue393.02
P/S476.29
P/B-1.03
EPS (TTM)-60.69
EPS (Forward)
52W Range
1.2085% of range21.20
52W High21.20 USD
52W Low1.208 USD
Profitability
Gross Margin100.00%
Oper. Margin-6815.30%
EBITDA Margin0.00%
Profit Margin0.00%
ROE833.76%
ROA-2162.69%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-7.87M $
CapEx (TTM)
FCF Margin-33254.71%
FCF Yield-71.28%
Net Debt-1.74M $
Net Debt/EBITDA0.18
Balance Sheet
Debt/Equity-0.48
Current Ratio0.19
Quick Ratio0.16
Book Value/Sh-2.1360 USD
Cash/Share0.6960 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:8
Split DateMay 22, 2026
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.4.53M
Float2.92M
Insiders40.72%
Institutions3.53%
Short Interest
Short Ratio3.5d
Short % Float3.46%
Short % Out.3.01%
Shares Short136.68K
Short (prev mo.)150.19K
Technical
SMA 502.729 (-21.0%)
SMA 2004.623 (-53.4%)
Beta0.32
S&P 52W Chg18.16%
Avg Vol (30d)329.16K
Avg Vol (10d)47.72K
Technical Indicators
RSI (14)39.4
MACD-0.1298
MACD Signal-0.1352
MACD Hist.+0.0054
BB Upper2.584 USD
BB Middle2.282 USD
BB Lower1.980 USD
BB Width26.46%
ATR (14)0.2797 USD
Vol Ratio (20d)0.05x